8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)
Published . Updated .
8-K - Mineralys Therapeutics filed an 8-K with the SEC on Oct 29 (a notice of a material company event).
Directly affected
- MLYS Mineralys Therapeutics-37.3% 14d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Mineralys Therapeutics belongs to, so it often moves with news about it.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and is a peer of Mineralys Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson is a peer of Mineralys Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+11.4% 30d
AbbVie is a peer of Mineralys Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.2% 18d
Merck is a peer of Mineralys Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+3.1% 30d
Abbott Laboratories is a peer of Mineralys Therapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MLYS | -3.25% | -0.49% | base | -14.45% | -19.19% | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-29 AccNo: 0001933414-26-000136 Size: 149 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement
Source: sec-edgar
How far Mineralys Therapeutics (MLYS) has moved since 29 Oct 2026
| Company | When | Move | Status |
|---|---|---|---|
| Mineralys Therapeutics (MLYS) | that day | -14.45% | final price |
| Mineralys Therapeutics (MLYS) | the next day | -19.19% | still updating |
| Mineralys Therapeutics (MLYS) | three days earlier | -0.49% | final price |
| Mineralys Therapeutics (MLYS) | five days earlier | -3.25% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 51 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 45 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought AbbVie (ABBV), worth $50,001 - $100,000 on 31 Jul 2026. That is 90 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 71 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 90 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 27 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 41 days before publication. Filed 12 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)”
Companies mentioned with this story
- MLYS Mineralys Therapeutics
Mineralys Therapeutics (MLYS) is linked, with no stored direction, high confidence in the 29 Oct 2026 story “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> MLYS
How “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)” reaches Mineralys Therapeutics (MLYS)
On 29 Oct 2026, “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)” is the story that connects Mineralys Therapeutics (MLYS) to this story.
For Mineralys Therapeutics (MLYS), the reason on file says SEC 8-K filing -> direct issuer disclosure -> MLYS
Price levels for Mineralys Therapeutics (MLYS)
MLYS traded between 18.11 and 28.98 across 13 sessions. The latest close on file is 18.17.
A simple score for Mineralys Therapeutics (MLYS)
14 out of 100Price not final
“8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.